<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08033439377278</udiDi>
    <basicUdiDi>8033439MONOFIL3T</basicUdiDi>
    <tradeName>08033439377278</tradeName>
    <deviceName>MONOFIL</deviceName>
    <manufacturerName>ASSUT EUROPE SPA</manufacturerName>
    <manufacturerSrn>IT-MF-000018178</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FV766FW</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-27T06:38:49.815Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904300138918</udiDi>
    <basicUdiDi>890430012015ULSSS0114L</basicUdiDi>
    <tradeName>M-MONO</tradeName>
    <deviceName>Monofilament Poliglecaprone 25 Suture</deviceName>
    <manufacturerName>Unisur Lifecare Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000008184</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11G45CY20U</reference>
    <placedOnMarketCountry>Greece</placedOnMarketCountry>
    <lastUpdated>2026-07-24T20:21:23.913Z</lastUpdated>
  </row>
  <row>
    <udiDi>08904300147392</udiDi>
    <basicUdiDi>890430012015ULSSS0114L</basicUdiDi>
    <tradeName>M-MONO</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Unisur Lifecare Private Limited</manufacturerName>
    <manufacturerSrn>IN-MF-000008184</manufacturerSrn>
    <authorisedRepresentativeName>CMC Medical Devices &amp; Drugs SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000000293</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>11E75DX38U</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-24T19:53:05.708Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927802334</udiDi>
    <basicUdiDi>B-10652927802334</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO284018F4P</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:59:40.740Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927790846</udiDi>
    <basicUdiDi>B-10652927790846</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO284019F6P</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:59:39.939Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927788416</udiDi>
    <basicUdiDi>B-10652927788416</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO286017B0P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:59:39.127Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927790594</udiDi>
    <basicUdiDi>B-10652927790594</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283037B0P</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:59:38.332Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927722113</udiDi>
    <basicUdiDi>B-10652927722113</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010302</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO3X1830</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:58:03.774Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927722090</udiDi>
    <basicUdiDi>B-10652927722090</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010302</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO3X1820</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:58:02.971Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927672654</udiDi>
    <basicUdiDi>B-10652927672654</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO285019F4P</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:57:32.165Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927414322</udiDi>
    <basicUdiDi>B-10652927414322</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283026B6P</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:57:20.702Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927389613</udiDi>
    <basicUdiDi>B-10652927389613</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283031B0P</reference>
    <placedOnMarketCountry>Cyprus</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:57:15.896Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927298984</udiDi>
    <basicUdiDi>B-10652927298984</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO285016F4P</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:57:10.490Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927299004</udiDi>
    <basicUdiDi>B-10652927299004</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO286013F4P</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:57:07.886Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927287520</udiDi>
    <basicUdiDi>B-10652927287520</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO285013B0P</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:57:03.088Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927287506</udiDi>
    <basicUdiDi>B-10652927287506</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO284026B0P</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:57:01.498Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927287469</udiDi>
    <basicUdiDi>B-10652927287469</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO284020B0P</reference>
    <placedOnMarketCountry>Portugal</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:57:00.677Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927287414</udiDi>
    <basicUdiDi>B-10652927287414</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO284017B0P</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:56:59.083Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927287315</udiDi>
    <basicUdiDi>B-10652927287315</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283026K0P</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:56:55.331Z</lastUpdated>
  </row>
  <row>
    <udiDi>10652927287292</udiDi>
    <basicUdiDi>B-10652927287292</basicUdiDi>
    <tradeName>DemeCAPRONE</tradeName>
    <deviceName>DemeCAPRONE</deviceName>
    <manufacturerName>DemeTECH Corp</manufacturerName>
    <manufacturerSrn>US-MF-000026972</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101010301</emdnCode>
    <emdnDescription>POLIGLECAPRONE AND DERIVATIVES MONOFILAMENT WITH NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>MO283026H0P</reference>
    <placedOnMarketCountry>Hungary</placedOnMarketCountry>
    <lastUpdated>2026-07-24T03:56:54.296Z</lastUpdated>
  </row>
</eudamedExport>